Prise en charge d'un malade atteint du syndrome des jambes sans repos [Management of restless legs syndrome].

Details

Serval ID
serval:BIB_C90BF1823971
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Title
Prise en charge d'un malade atteint du syndrome des jambes sans repos [Management of restless legs syndrome].
Journal
Presse Médicale (paris, France : 1983)
Author(s)
Haba-Rubio J., Krieger J.
ISSN
0755-4982 (Print)
ISSN-L
0755-4982
Publication state
Published
Issued date
2010
Volume
39
Number
5
Pages
571-578
Language
french
Notes
Publication types: English Abstract ; Journal Article ; Review
Publication Status: ppublish
Abstract
The first step in the management of restless legs syndrome (RLS) is to identify, and if possible to treat any condition which might cause or worsen RLS, such as iron deficiency or some drug treatments. The patients suffering from RLS should be prompted to keep a healthy sleep schedule. Drug treatment should be restricted to patients with a clear clinical diagnosis, decided on an individual basis, when the clinical impact is serious. Four drug classes are central to the treatment of RLS: dopaminergic agents, some antiepileptics, opioids, and benzodiazepines. Dopaminergic agonists are the treatment of choice, especially when daily treatment is indicated, or if the symptoms are severe. Two dopaminergic agonists are licensed in France for the treatment of RLS: ropinirole (Adartrel) and pramipexole (Sifrol). After initiation of treatment, the patients should benefit from a regular follow-up in order to evaluate the efficacy of treatment and to identify possible side-effects. Special care should be given to the detection of augmentation, a phenomenon characterized by a paradoxical worsening of the symptoms with treatment. Some particular conditions, such as RLS comorbid with renal insufficiency, during pregnancy, and in the child are discussed.
Keywords
Analgesics, Opioid/therapeutic use, Anticonvulsants/therapeutic use, Benzodiazepines/therapeutic use, Child, Dopamine Agents/therapeutic use, Drug Monitoring, Female, Follow-Up Studies, Humans, Pregnancy, Pregnancy Complications, Restless Legs Syndrome/complications, Restless Legs Syndrome/drug therapy, Sleep/physiology
Pubmed
Create date
24/04/2016 10:10
Last modification date
19/11/2019 6:26
Usage data